Free Trial
CVE:NVH

Novoheart (NVH) Stock Price, News & Analysis

C$0.53 +0.01 (+1.92%)
(As of 11/20/2020)

About Novoheart Stock (CVE:NVH)

Key Stats

Today's Range
C$0.52
C$0.53
50-Day Range
C$0.53
C$0.53
52-Week Range
C$0.26
C$0.72
Volume
23,066 shs
Average Volume
33,593 shs
Market Capitalization
C$99.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Novoheart Holdings Inc. operates as a stem cell biotechnology company in the United States. The company offers an array of next-generation human heart tissue prototypes. It provides MyHeart platform products, including human pluripotent stem cell-derived cardiomyocytes, human ventricular cardiac anisotropic sheet assays, and human ventricular cardiac tissue strips assays. The company also offers screening and phenotyping services; and consultation services, including mapping and designing preclinical studies that involve human embryonic or induced pluripotent stem cell-derived cardiomyocytes, prototyping custom bioreactor designs, and developing custom software for streamlining of screening platforms and analysis of acquired data. Novoheart Holdings Inc. has a collaboration with AstraZeneca to develop human-specific in vitro functional model of heart failure with preserved ejection fraction. The company is based in Vancouver, Canada.

Receive NVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novoheart and its competitors with MarketBeat's FREE daily newsletter.

NVH Stock News Headlines

Capgemini SE (CAP.PA)
067570.KQ - NVH Korea Inc.
What This Post-Election Shift Means for Your Investments
The election may be over, but its impact on financial markets is only beginning. New trends are emerging, bringing both challenges and opportunities for investors. Many of these changes are flying under the radar, yet they have the potential to reshape the financial landscape for years to come. Understanding how these shifts could affect your wealth—and what steps to take—has never been more important.
NVH Korea Inc (067570)
Novoheart Holdings Inc (NVH)
See More Headlines

NVH Stock Analysis - Frequently Asked Questions

Novoheart's stock was trading at C$0.53 at the beginning of 2024. Since then, NVH shares have increased by 0.0% and is now trading at C$0.53.
View the best growth stocks for 2024 here
.

Shares of NVH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Novoheart investors own include Athabasca Oil (ATH), Black Iron (BKI), Berry (BRY), Castor Maritime (CTRM), IT Tech Packaging (ITP), SOS (SOS) and Sarepta Therapeutics (SRPT).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$423,500.00
Cash Flow
C$0.07 per share
Book Value
C$0.12 per share

Miscellaneous

Free Float
N/A
Market Cap
C$99.98 million
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (CVE:NVH) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners